| pubmed-article:2188845 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2188845 | lifeskim:mentions | umls-concept:C0042960 | lld:lifeskim |
| pubmed-article:2188845 | lifeskim:mentions | umls-concept:C1549078 | lld:lifeskim |
| pubmed-article:2188845 | lifeskim:mentions | umls-concept:C1997894 | lld:lifeskim |
| pubmed-article:2188845 | lifeskim:mentions | umls-concept:C0010581 | lld:lifeskim |
| pubmed-article:2188845 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
| pubmed-article:2188845 | lifeskim:mentions | umls-concept:C0205307 | lld:lifeskim |
| pubmed-article:2188845 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:2188845 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:2188845 | lifeskim:mentions | umls-concept:C0205251 | lld:lifeskim |
| pubmed-article:2188845 | lifeskim:mentions | umls-concept:C0439858 | lld:lifeskim |
| pubmed-article:2188845 | lifeskim:mentions | umls-concept:C0458083 | lld:lifeskim |
| pubmed-article:2188845 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:2188845 | pubmed:dateCreated | 1990-6-29 | lld:pubmed |
| pubmed-article:2188845 | pubmed:abstractText | In this study we compared low (125 micrograms) and conventional (500 micrograms) doses of cyclopenthiazide on the renin angiotensin system, plasma and extracellular fluid volumes and the pressor responsiveness to angiotensin II since we have previously shown that the two doses have the same antihypertensive effect but different effects on plasma renin activity. Following a two week placebo run-in period, 8 healthy male volunteers received 125 micrograms or 500 micrograms of cyclopenthiazide for 2 treatment periods of 4 weeks as part of a double blind, 2-part crossover study with treatment periods separated by a 4-week placebo washout phase. Measurements were made on two study days at the beginning and end of the active treatment periods. On the first day serum potassium, plasma renin activity and plasma angiotensin II levels were measured after a 1 h period of supine rest. Plasma and extracellular fluid volumes were also measured after appropriate equilibration times. The blood pressure responses to angiotensin II were assessed on day 2. The 500 micrograms dose of cyclopenthiazide had a greater effect than the 125 micrograms dose on plasma renin activity, serum potassium, angiotensin II levels and extracellular fluid volumes. Neither drug had any effect on plasma volume or the responsiveness to infused angiotensin II. Low dose cyclopenthiazide failed to increase angiotensin II levels, contract body fluid volumes or attenuate vascular reactivity in normotensive volunteers. | lld:pubmed |
| pubmed-article:2188845 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2188845 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2188845 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2188845 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2188845 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2188845 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2188845 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2188845 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2188845 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2188845 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2188845 | pubmed:issn | 0031-6970 | lld:pubmed |
| pubmed-article:2188845 | pubmed:author | pubmed-author:JohnstonG DGD | lld:pubmed |
| pubmed-article:2188845 | pubmed:author | pubmed-author:WhiteheadEE | lld:pubmed |
| pubmed-article:2188845 | pubmed:author | pubmed-author:McMasterMM | lld:pubmed |
| pubmed-article:2188845 | pubmed:author | pubmed-author:McVeighG EGE | lld:pubmed |
| pubmed-article:2188845 | pubmed:author | pubmed-author:LintonTT | lld:pubmed |
| pubmed-article:2188845 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2188845 | pubmed:volume | 38 | lld:pubmed |
| pubmed-article:2188845 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2188845 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2188845 | pubmed:pagination | 351-7 | lld:pubmed |
| pubmed-article:2188845 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2188845 | pubmed:meshHeading | pubmed-meshheading:2188845-... | lld:pubmed |
| pubmed-article:2188845 | pubmed:meshHeading | pubmed-meshheading:2188845-... | lld:pubmed |
| pubmed-article:2188845 | pubmed:meshHeading | pubmed-meshheading:2188845-... | lld:pubmed |
| pubmed-article:2188845 | pubmed:meshHeading | pubmed-meshheading:2188845-... | lld:pubmed |
| pubmed-article:2188845 | pubmed:meshHeading | pubmed-meshheading:2188845-... | lld:pubmed |
| pubmed-article:2188845 | pubmed:meshHeading | pubmed-meshheading:2188845-... | lld:pubmed |
| pubmed-article:2188845 | pubmed:meshHeading | pubmed-meshheading:2188845-... | lld:pubmed |
| pubmed-article:2188845 | pubmed:meshHeading | pubmed-meshheading:2188845-... | lld:pubmed |
| pubmed-article:2188845 | pubmed:meshHeading | pubmed-meshheading:2188845-... | lld:pubmed |
| pubmed-article:2188845 | pubmed:meshHeading | pubmed-meshheading:2188845-... | lld:pubmed |
| pubmed-article:2188845 | pubmed:meshHeading | pubmed-meshheading:2188845-... | lld:pubmed |
| pubmed-article:2188845 | pubmed:meshHeading | pubmed-meshheading:2188845-... | lld:pubmed |
| pubmed-article:2188845 | pubmed:meshHeading | pubmed-meshheading:2188845-... | lld:pubmed |
| pubmed-article:2188845 | pubmed:meshHeading | pubmed-meshheading:2188845-... | lld:pubmed |
| pubmed-article:2188845 | pubmed:meshHeading | pubmed-meshheading:2188845-... | lld:pubmed |
| pubmed-article:2188845 | pubmed:year | 1990 | lld:pubmed |
| pubmed-article:2188845 | pubmed:articleTitle | A comparison of the haemodynamic and hormonal effects of low and conventional dose cyclopenthiazide in normal volunteers. | lld:pubmed |
| pubmed-article:2188845 | pubmed:affiliation | Department of Therapeutics and Pharmacology, Queen's University of Belfast, Northern Ireland, U.K. | lld:pubmed |
| pubmed-article:2188845 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2188845 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:2188845 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:2188845 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
